B+
Bull case
20%
Probability
Target price
$1.20
Analysis reference price unavailable
Analysis 2026-10-20 · RankAlpha Sentiment Codex
EYPT
EyePointANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
DURAVYU showed reduced treatment burden in LUCIA despite missing non-inferiority, and the separate DME program remains in Phase 3. Restructuring could preserve capital until its expected Q4 2027 readouts, but that runway has not been confirmed after the strategic reset.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +3.5.
What can break
LUCIA and LUGANO both missed wet-AMD non-inferiority; favorable secondary endpoints do not reverse those primary-endpoint failures. SEC-filed LUCIA release
Momentum
1
Value
58
Sentiment
79
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.45 · Bull $1.20 · Bear $0.15Analysis 2026-10-20; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-20 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $12.39
Why
Momentum1 · Δ7d +0.1
Value58 · Δ7d +16.8
Sentiment79 · Δ7d +3.5
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +3.5.
Contradictions & invalidation
- • LUCIA and LUGANO both missed wet-AMD non-inferiority; favorable secondary endpoints do not reverse those primary-endpoint failures. SEC-filed LUCIA release
- • Sub-$1 share price, potential financing or dilution, and thin post-event analyst coverage increase downside uncertainty.
- • Both pivotal wet-AMD trials missed their primary endpoints and EyePoint is ending them early, materially weakening the prior wet-AMD thesis.
Catalyst clock
2026-11-19
Repricing after LUCIA's failed primary endpoint
Lead driver: Sentiment · See AI snapshot
Momentum
1
8% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.1
Value
58
47% active weight
Current posture
7d trendImproving
Δ7d
+16.8
Δ21d
+16.5
Sentiment
79
45% active weight
Current posture
7d trendImproving
Δ7d
+3.5
Δ21d
-26.9
Why this grade
Composite grade A. Momentum 1.4 / Value 57.5 / Sentiment 79.2
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-20. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$0.45
Analysis reference price unavailable
Analysis 2026-10-20 · RankAlpha Sentiment Codex
B-
Bear case
35%
Probability
Target price
$0.15
Analysis reference price unavailable
Analysis 2026-10-20 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$34.87M
Beta
1.78
Shares Out
86.21M
P/E (TTM) · Derived
-0.1
P/S (TTM)
34.08
P/FCF (TTM) · Derived
-0.12
Rev YoY
-90.5%
EPS YoY
+28.5%
Gross Margin
-18.3%
Op Margin
-11365.2%
Net Debt
-$283.29M
Current Ratio
4.50
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data